FPF
NEOS

FNY Partners Fund’s Neos Therapeutics, Inc NEOS Stock Holding History

FNY Partners Fund’s Portfolio NEOS Stock Details NEOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-7,000
Closed -$71K – 520
2017
Q4 		$71K Buy
+7,000
New +$67.2K 0.01% 231
2017
Q2 		– Sell
-12,118
Closed -$87K – 1306
2017
Q1 		$87K Buy
+12,118
New +$75.2K 0.01% 558

Other funds holding NEOS

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
LSC
Lyon Street Capital Sausalito, California $67M AUM
JGC
J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
CAM
Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return
GTC
Ghost Tree Capital New York $331M AUM 70.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

FNY Partners Fund's NEOS Position: Q1 2018 in Review

FNY Partners Fund sold out of Neos Therapeutics, Inc (NEOS) in Q1 2018, closing a stake of 7,000 shares — an estimated $71K sold.

FNY Partners Fund first reported a position in NEOS in Q1 2017 and held it in 2 quarters. The position peaked at $87K in Q1 2017. 77 funds tracked by Wall St. Rank hold NEOS as of Q1 2018.

  • FNY Partners Fund reported no remaining Neos Therapeutics, Inc position as of Q1 2018 after selling out during the quarter.
  • FNY Partners Fund sold 7,000 Neos Therapeutics, Inc shares in Q1 2018, an estimated $71K.
  • FNY Partners Fund first reported a position in Neos Therapeutics, Inc in Q1 2017 and held it in 2 quarters.
  • FNY Partners Fund's Neos Therapeutics, Inc position peaked at $87K in Q1 2017.
  • 77 funds tracked by Wall St. Rank held Neos Therapeutics, Inc as of Q1 2018.

Based on FNY Partners Fund's 13F filing for Q1 2018, filed 18 Apr 2018.